Biotechnology · Healthcare
CEO, Chairman, Board Member
2025-11-06–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Canton Strategic Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get CNTN alertsMark Wendland is recorded as Chairman at Canton Strategic Holdings, Inc. (CNTN) since February 5, 2026, Board Member at Canton Strategic Holdings, Inc. (CNTN) since November 6, 2025 and CEO at Canton Strategic Holdings, Inc. (CNTN). The newest filing on record that lists Mark Wendland as CEO at Canton Strategic Holdings, Inc. (CNTN) is dated June 25, 2026. Canton Strategic Holdings, Inc. reported in an 8-K filed February 6, 2026 that Mark Wendland was appointed Chairman of the Board, effective February 5, 2026. Canton Strategic Holdings, Inc. reported in an 8-K filed November 6, 2025 that Mark Wendland was appointed director of the Board, effective November 6, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed November 6, 2025 that Mark Wendland was appointed Chief Executive Officer, effective November 6, 2025. The proxy statement of Canton Strategic Holdings, Inc. reports total compensation of $358,333 for Mark Wendland in fiscal 2025, including a base salary of $83,333. Disclosed compensation is on record for 3 fiscal years. Canton Strategic Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Canton Strategic Holdings, Inc. includes Sireesh Appajosyula (CEO and CFO), Vincent LoPriore (Chairman), Don Kim (CFO) and 7 others.
“On February 5, 2026, during a special meeting of the Board of Directors, Mark Wendland, current Director and Chief Executive Officer of the Company, was elected as the Chairman of the Board.”
“on November 6, 2025, Mark Wendland was appointed as Chief Executive Officer of the Company and as a director of the Board and Mark Toomey was appointed as President of the Company.”
2026-02-05–present
2025-11-06–present
Start not stated–present
Last confirmed June 25, 2026
Biotechnology · Healthcare
CEO, Chairman, Board Member
2025-11-06–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Canton Strategic Holdings, Inc. (CNTN) | Chief Executive Officer | $83,333 | $358,333 |
| 2024 | Canton Strategic Holdings, Inc. (CNTN) | Chief Executive Officer | $0 | $0 |
| 2023 | Canton Strategic Holdings, Inc. (CNTN) | Chief Executive Officer | $0 | $0 |